Initial public offering of Cinlus Pharma AB (SE) on Nasdaq Stockholm – SEK 715 million Healthcare Initial public offering of Cinlus Pharma AB (SE) on Nasdaq Stockholm – SEK 715 million
Directed new share issue in Gruvaktiebolaget Viscaria (SE) — SEK 440 million Cleantech, Renewables & Infrastructure Directed new share issue in Gruvaktiebolaget Viscaria (SE) — SEK 440 million
Strategic partnership with Shandong Innovation Group by Gränges Business Services Strategic partnership with Shandong Innovation Group by Gränges
Recommended public cash offer to shareholders in Resurs Holding AB — SEK 4,700 million FIG Recommended public cash offer to shareholders in Resurs Holding AB — SEK 4,700 million
Reverse merger of Flerie Invest AB (SE) and InDex Pharmaceuticals – SEK 3,073 million Healthcare Reverse merger of Flerie Invest AB (SE) and InDex Pharmaceuticals – SEK 3,073 million
Directed new share issue in Flerie AB (SE) — SEK 607 million Healthcare Directed new share issue in Flerie AB (SE) — SEK 607 million
Placing of shares in RVRC Holding AB (SE) — SEK 400 million Consumer & Retail Placing of shares in RVRC Holding AB (SE) — SEK 400 million
Senior secured bond tap issue by SIBS AB (SE) – SEK 100 million Real Estate Senior secured bond tap issue by SIBS AB (SE) – SEK 100 million
Placing of shares in Truecaller AB (SE) — SEK 518 million TMT Placing of shares in Truecaller AB (SE) — SEK 518 million
Sale of Helios Nordic Energy AB (SE) to VINCI Concessions (FR) Cleantech, Renewables & Infrastructure Sale of Helios Nordic Energy AB (SE) to VINCI Concessions (FR)
Rights issue in Lyckegård Group AB (SE) — SEK 28 million Cleantech, Renewables & Infrastructure Rights issue in Lyckegård Group AB (SE) — SEK 28 million
Directed share issue in Irisity AB (SE) – SEK 45 million TMT Directed share issue in Irisity AB (SE) – SEK 45 million